Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 16 min 33 sec ago

Curis Announces Expansion of Executive Team

Wed, 03/30/2016 - 15:25
James Dentzer joins Curis as Chief Financial and Chief Administrative Officer David Tuck, M.D. is promoted to Chief Medical Officer and Mani Mohindru, Ph.D. is promoted to Chief Strategy Officer LEXINGTON, Mass., March 30, 2016 -- (Healthcare Sales &...
Biopharmaceuticals, Oncology, Personnel

Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery

Wed, 03/30/2016 - 15:22
NORRTALJE, Sweden and PETALUMA, Calif., March 30, 2016 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS) (OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological ...
Biopharmaceuticals, Drug Delivery, Dermatology
Oculus Innovative Sciences, Lipogrid

Retina Implant Secures CE Mark for Wireless Subretinal Implant

Wed, 03/30/2016 - 14:58
CE certification enables commercialisation of Alpha AMS device to restore some useful vision in patients blinded by retinitis pigmentosa REUTLINGEN, Germany, March 30, 2016 -- (Healthcare Sales & Marketing Network) -- Retina Implant AG, the leading dev...
Devices, Ophthalmology, Regulatory
Retina Implant AG, Alpha AMS, Subretinal Implant, retinal implant

Oncothyreon Appoints Scott D. Myers Chief Executive Officer

Tue, 03/29/2016 - 15:49
SEATTLE, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Oncothyreon Inc. (ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products to improve the lives and outcomes of patients with cancer, today a...
Biopharmaceuticals, Oncology, Personnel
Oncothyreon, ONT-380

Getinge Group Receives Innovative Technology Designation from Novation for the Maquet InterValve V8(TM) Balloon Aortic Valvuloplasty Catheter and the Maquet ClearFlow PleuraFlow(R) Active Clearance Technology(R) (ACT(TM)) System

Tue, 03/29/2016 - 15:47
Designation recognizes the development of new solutions that benefit the healthcare industry WAYNE, N.J., March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Getinge Group announced its Maquet V8 Catheter and Maquet PleuraFlow Active Clearance ...
Devices, Cardiology, Surgery, Group Purchasing
Getinge Group, Novation, Maquet V8, Valvuloplasty, aortic valve, PleuraFlow

Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration

Tue, 03/29/2016 - 15:42
REMOXY NDA Has Priority Review AUSTIN, Texas, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Pain Therapeutics, Inc. (PTIE) announced today that it has resubmitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) ...
Biopharmaceuticals, Drug Delivery, FDA
Pain Therapeutics, REMOXY, oxycodone

FDA-Cleared DigniCap(R) Scalp Cooling System Is Now Available For Women With Breast Cancer At 10 U.S. Cancer Treatment Centers

Tue, 03/29/2016 - 15:39
First and Only FDA Cleared Scalp Cooling Device To Reduce Chemotherapy Related Hair Loss Provides an Alternative to One of the Most Devastating Side Effects Feared by Patients with Breast Cancer DALLAS, March 29, 2016 -- (Healthcare Sales & Marketing Ne...
Devices, Oncology, Product Launch
Dignitana, DigniCap, Scalp Cooling, chemotherapy

Shire Wins Patent Trial Against Watson Concerning LIALDA(R)

Tue, 03/29/2016 - 15:34
LIALDA Patent Upheld and Extends through June 8, 2020 LEXINGTON, Massachusetts, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Shire plc (LSE: SHP, NASDAQ: SHPG) and its subsidiary, Shire Development LLC, announced today that the United St...
Biopharmaceuticals, Generics, Litigation
Shire plc, LIALDA, mesalamine, Watson Pharmaceuticals, ulcerative colitis

Bluegrass Vascular Technologies Announces First Clinical Use of the Surfacer(R) Inside-Out(R) Access Catheter System in Europe

Tue, 03/29/2016 - 15:30
The Surfacer System enables end-stage renal disease patient with obstructed central veins to continue hemodialysis therapy SAN ANTONIO, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies, Inc. (BVT), a private m...
Bluegrass Vascular Technologies, Surfacer, Inside-Out, Access Catheter, dialysis

Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis

Tue, 03/29/2016 - 13:33
Non-invasive and non-radioactive test can be administered in any clinical setting Analysis of patient breath samples performed in a CLIA-certified lab Validated against gastric scintigraphy BRENTWOOD, Tenn., March 29, 2016 -- (Healthcare Sales & M...
Diagnostics, Gastroenterology, Product Launch
Cairn Diagnostics, gastroparesis, 13C-Spirulina, Gastric Emptying

Lannett Receives FDA Approvals For Two Products

Tue, 03/29/2016 - 13:26
Company Expects to Launch Temolozomide Capsules Shortly PHILADELPHIA, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA...
Biopharmaceuticals, Generics, FDA
Lannett Company, Temolozomide, Potassium Chloride

Adamis Pharmaceuticals Announces Agreement to Acquire US Compounding

Tue, 03/29/2016 - 13:20
SAN DIEGO, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Adamis Pharmaceuticals Corporation (ADMP) (“Company” or “Adamis”) announced today that it has entered into a definitive merger agreement (the “Agreement”) to acquire US Compounding, Inc...
Biopharmaceuticals, Mergers & Acquisitions
Adamis Pharmaceuticals, US Compounding, drug compounding

Via Surgical Ltd. Announces the Appointment of John Gomes as its Chief Commercial Officer

Tue, 03/29/2016 - 13:14
AMIRIM, Israel, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today that it has appointed John Gomes as its Chief C...
Devices, Surgery, Personnel
Via Surgical, FasTouch, hernia repair

Lion Biotechnologies Names Michael T. Lotze Chief Scientific Officer

Mon, 03/28/2016 - 21:30
NEW YORK, NY--(Healthcare Sales & Marketing Network) - Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced the appointment of Michael T. L...
Biopharmaceuticals, Oncology, Personnel
Lion Biotechnologies, melanoma

Easy and Effective Functional Test for Pediatric Ophthalmology Assessment with RETeval Complete(TM) Touted by Early Adopters

Mon, 03/28/2016 - 13:48
GAITHERSBURG, Md., March 28, 2016 -- (Healthcare Sales & Marketing Network) -- Jim Datovech, President of LKC Technologies, Inc. said, "We are learning from a number of ophthalmologists just how fast, easy, and effective functional testing of the ret...
Devices, Ophthalmology
LKC Technologies, RETeval Complete, Electroretinogram

Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA(TM)

Mon, 03/28/2016 - 13:41
MILTON, Ontario, March 28, 2016 -- (Healthcare Sales & Marketing Network) -- Aralez Pharmaceuticals Inc. (ARLZ) (ARZ.TO) ("Aralez" or the "Company"), a global specialty pharmaceutical company, today announced that the U.S. Food and Dru...
Biopharmaceuticals, Cardiology, FDA
Aralez Pharmaceuticals, YOSPRALA, aspirin therapy

Glaukos iStent(R) Trabecular Micro-Bypass Stent Approved in Japan

Mon, 03/28/2016 - 13:34
Approved by the MHLW for Use in Combination with Cataract Surgery, iStent Will Be First-Ever Ab Interno Micro-Scale Glaucoma Device Available in Japan LAGUNA HILLS, Calif.--(Healthcare Sales & Marketing Network)--Glaukos Corporation (GKOS), an ophthalm...
Devices, Ophthalmology, Regulatory
Glaukos, iStent , glaucoma

First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet

Mon, 03/28/2016 - 13:23
Early Experience in Class III Heart Failure Patients was Favorable CAESAREA, Israel--(Healthcare Sales & Marketing Network)--V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced today ...
Devices, Cardiology
V-Wave, interatrial shunt, heart failure, V-Wave Shunt

Hemostemix Appoints Hardean E. Achneck, M.D. as Chief Medical Officer

Fri, 03/25/2016 - 14:15
TORONTO, ON--(Healthcare Sales & Marketing Network) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM) (OTCQX: HMTXF), a clinical-stage autologous cell therapy company, announced today the promotion of Hardean E. Achne...
Regenerative Medicine, Personnel
Hemostemix, stem cell, critical limb ischemia

Ajanta Pharma Announces the Launch of Levetiracetam Tablets

Thu, 03/24/2016 - 15:33
BRIDGEWATER, N.J., March 24, 2016 -- (Healthcare Sales & Marketing Network) -- Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announces today the launch of Levetiracetam Immediate-Release Tablets (250mg, 500mg, 750mg, 1000mg), a b...
Biopharmaceuticals, Generics, Product Launch
Ajanta Pharma, Levetiracetam, Keppra, UCB Pharma

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong